-
1
PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
Published 2017-08-01Subjects: Get full text
Article -
2
Influence of age of onset of psoriasis on prevalence and clinical characteristics of psoriatic arthritis (according to the registry of patients with psoriasis)
Published 2022-09-01Subjects: “…psoriasis…”
Get full text
Article -
3
New opportunities in the treatment of psoriasis and psoriatic arthritis
Published 2019-01-01Subjects: “…psoriasis…”
Get full text
Article -
4
Epidemiology of psoriasis among the elderly population and volume of specialized medical care provided to patients with psoriasis in the Russian Federation in 2010–2019
Published 2020-12-01Subjects: “…psoriasis…”
Get full text
Article -
5
Clinical and economic analysis of biologic drugs in treatment of psoriasis
Published 2018-05-01Subjects: Get full text
Article -
6
Can the development of psoriatic arthritis be prevented in patients with psoriasis?
Published 2019-07-01Subjects: “…psoriasis…”
Get full text
Article -
7
Revisited the potential risks of carcinogenicity of phototherapy in patients with psoriasis
Published 2017-08-01Get full text
Article -
8
Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
Published 2019-12-01Subjects: “…plaque psoriasis…”
Get full text
Article -
9
Prevalence of genetic risk factors of psoriasis among the population of the Russian Federation
Published 2017-08-01Subjects: Get full text
Article -
10
Molecular markers of the risk of development of skin cancer in psoriasis patients receiving a phototherapy
Published 2017-08-01“…Biological blood samples taken from 47 psoriasis patients, 24 patients with malignant skin melanomas and 20 healthy subjects. …”
Get full text
Article -
11
Genetic markers for psoriatic arthritis among patients with psoriasis. Part II: HLA genes
Published 2021-12-01“…Early identification of patients with psoriasis with an increased risk of developing psoriatic arthritis for the purpose of its timely diagnosis and early initiation of therapy can prevent the development of severe disease outcomes. …”
Get full text
Article -
12
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis
Published 2018-01-01Subjects: “…psoriasis…”
Get full text
Article -
13
Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext
Published 2019-10-01Subjects: “…psoriasis…”
Get full text
Article -
14
-
15
Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis
Published 2019-07-01Subjects: “…psoriasis…”
Get full text
Article -
16
Resolution of the Council of Russian Experts: Apremilast, a phosphodiesterase 4 inhibitor, as a representative of a new class of small molecule compounds: Its place in the treatment of moderate or severe psoriasis and psoriatic arthritis
Published 2017-03-01“…On November 26, 2016, Moscow hosted an Interdisciplinary Council of Russian Experts in Dermatology and Rheumatology, which discussed the unsolved problems and new possibilities of therapy for psoriasis (Ps) and psoriatic arthritis (PsA). The meeting was attended by leading experts in rheumatology and dermatology. …”
Get full text
Article -
17
THE ASSESSMENT OF THE INCIDENCE OF SKIN DISORDERS IN RUSSIAN FEDERATION IN 2003–2016
Published 2018-02-01Subjects: “…incidence and prevalence of atopic dermatitis and psoriasis…”
Get full text
Article -
18
Personalization of an anti-cytokine therapy of psoriatic patients
Published 2017-08-01Subjects: Get full text
Article -
19
Diagnostic value of the confocal laser scanning microscopy in vivo
Published 2017-08-01“…To assess the confocal laser scanning microscopy in vivo (CLSM) technique for diagnosing actinic keratosis, psoriasis vulgaris and rosacea vs. the classical histology examination. …”
Get full text
Article